Comparison of Second and First Generation of Andexanet Alfa in a Porcine Polytrauma Model with Apixaban Anticoagulation
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-114542
Abstract: Background Andexanet alfa (AnXa; Andexxa) was developed as a specific antidote for direct and indirect factor Xa (FXa) inhibitors. It has been approved in the US for the reversal of apixaban and rivaroxaban anticoagulation when… read more here.
Keywords: anxa; anti fxa; fxa activity; generation ... See more keywords
Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-125955
Abstract: Normal hemostasis is desired prior to invasive procedures such as surgery. For emergent surgeries, where waiting for an anticoagulant to wear off is not an option, reversal agents or antidotes are often administered. However, for… read more here.
Keywords: administration; heparinization; anxa; act ... See more keywords
[Evaluation of Annexin-1 (ANXA-1), Annexin-2 (ANXA-2) and Bone Morphogenetic Protein-7 (BMP-7) Serum Levels in Patients Followed Up With A Diagnosis of COVID-19].
Sign Up to like & getrecommendations! Published in 2022 at "Mikrobiyoloji bulteni"
DOI: 10.5578/mb.20229903
Abstract: Coronavirus disease 2019 (COVID-19) is a global health problem caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection may present with clinical pictures ranging from asymptomatic or mild forms to respiratory failure requiring intensive… read more here.
Keywords: anxa; involvement; lung involvement; covid ... See more keywords